ACCL2031, A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors (CTMS# 22-0131)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Anne–Marie Langevin MD

For more information about this study

View Details